Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online before the meeting...these abstracts will be available in the Abstract Book at the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

NOTES:
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


Download Flyer

Twitter hashtag for this meeting: #KSmicroglia

Microglia in the Brain (Z4)

joint with the meeting on Common Mechanisms of Neurodegeneration (Z3)

Scientific Organizers: Beth Stevens and Richard M. Ransohoff


June 12—16, 2016

Keystone Resort, Keystone, Colorado, USA


Sponsored by BioLegend, Inc., Ionis Pharmaceuticals, Inc. and Merck & Co., Inc.


Abstract submission is closed. Registered attendees can bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
Scholarship Deadline: Feb 11, 2016 [details]
Discounted Abstract Deadline: Feb 11, 2016 [details]
Abstract Deadline: Mar 10, 2016 [details]
Discounted Registration Deadline: Apr 12, 2016 [details]

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2016-Z4 "Microglia in the Brain" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On February 11, 2016 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After February 11, 2016 until April 29, 2016 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
February 11, 2016 n/a
Discounted NON-STUDENT Registration
More details
Before and On April 12, 2016 795.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details
After April 12, 2016 945.00 USD
Discounted STUDENT Registration
More details
Before and On April 12, 2016 570.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details
After April 12, 2016 720.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: February 11, 2016


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract in the meeting Abstract Book
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is March 10, 2016)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: February 11, 2016


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: March 10, 2016


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract in the meeting Abstract Book
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is February 11, 2016)

Discounted Registration Deadline: April 12, 2016


Registration Fee: 795.00 USD* (includes 150.00 USD discount)
Student Registration Fee: 570.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 945.00 USD*
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, June 12 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, June 16 with a closing plenary session and keynote address from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, June 17 in order to fully experience the meeting.

SUNDAY, JUNE 12

16:00—20:00
Arrival and Registration

Longs Peak Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, JUNE 13

07:30—08:30
Breakfast

Quandary Peak
08:30—09:30
Welcome and Keynote Address
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Beth Stevens, Children's Hospital Boston, USA

Christopher K. Glass, University of California, San Diego, USA
The Nature and Nurture of Macrophage Identity and Function

08:30—09:30
Welcome and Keynote Address
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
* Bradley T. Hyman, Massachusetts General Hospital, USA

Laura Ranum, University of Florida, USA
Repeat Associated Non-ATG (RAN) Translation: New Starts and Directions in Neurologic Disease

09:30—12:15
Genetics to Pathogenesis
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Richard M. Ransohoff, Biogen, USA

Zbigniew K. Wszolek, Mayo Clinic College of Medicine, USA
Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia due to CSF1R gene Mutations: Clinical, Radiological, Pathological and Genetic Correlations

Coffee Break

Steven G. Younkin, Mayo Clinic Jacksonville, USA
Association of Variants in Microglial Genes with Neurodegenerative Disease

Karel Otero Gutierrez, Biogen, USA
Investigating the Functions of TREM2 in Neurodegneration

Michael W. Salter, Hospital for Sick Children and University of Toronto, Canada
Sexual Dimorphism in Microglia-Neuron Signaling in Pain Neuroplasticity

09:30—11:45
Prions and “Prionoid” Molecules
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
Beat H. Meier, ETH Zürich, Switzerland
Atomic-Resolution Structures of Amyloids: HET-s and Different Polymorphs of Amyloid Beta: What Can We Learn?

Coffee Break

* Adriano M. Aguzzi, University Hospital of Zürich, Switzerland
Prion Toxicity

Tuomas Knowles, University of Cambridge, UK
Kinetics of Protein Aggregation

Kristen Anne Davenport, Colorado State University, USA
Short Talk: Dissecting the Role of the PrP Amino Terminus in Species Barriers

12:15—17:00
On Own for Lunch

12:15—13:00
Poster Setup

Quandary Peak
13:00—22:00
Poster Viewing

Quandary Peak
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:15
Microglia Surveillance in Real Time: Lessons from in vivo Imaging
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Marie-Ève Tremblay, Laval University, Canada

David Attwell, University College London, UK
An Ion Channel Regulating Microglial Surveillance of the Brain Parenchyma

Dimitrios Davalos, Lerner Research Institute, Cleveland Clinic, USA
Microglial Responses to Blood Brain Barrier Breakdown

Francesca Peri, European Molecular Biology Laboratory, Germany
Microglia Go Live: The Role Neuronal-Microglial Interactions in the Development and Repair of the CNS

Courtney N. Easley-Neal, Genentech, Inc., USA
Short Talk: Cerebral Cortex Targeted Depletion of Microglia, via CSF1R Ligand Inhibition, as a Potential Approach to Mitigate Neurodegeneration in Alzheimer’s Disease

Deborah Kurrasch, University of Calgary, Canada
Short Talk: Microglia Influence Embryonic Development of Hypothalamic Energy Balance Centers

17:00—19:00
Protein Templating and Spread of Neuropathology
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
Mathias Jucker, Hertie-Institute for Clinical Brain Research and DZNE, Germany
Proteopathic Seeds in Neurodegenerative Diseases

* Bradley T. Hyman, Massachusetts General Hospital, USA
Neuroanatomy and Consequences of Pathological Propagation in Neurodegeneration

Virginia M. Y. Lee, University of Pennsylvania School of Medicine, USA
New Tauopathy Mouse Models for Alzheimer’s Disease

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Quandary Peak
19:30—22:00
Poster Session 1

Quandary Peak

TUESDAY, JUNE 14

07:30—08:30
Breakfast

Quandary Peak
08:00—08:30
Poster Setup

Quandary Peak
08:30—17:00
Poster Viewing

Quandary Peak
08:30—11:30
Synaptic Pruning and Plasticity
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Cornelius Gross, European Molecular Biology Laboratory, Italy

Dorothy Schafer, University of Massachusetts Medical School, USA
Microglia: Dynamic Sensors of Neural Activity and Regulators of Brain Plasticity

Rosa C. Paolicelli, University of Zurich, Switzerland
TDP-43 Loss in Microglia Promotes Phagocytosis and affects Synaptic Pruning and Motor Behavior in Adult Mice

Coffee Break

Brian MacVicar, University of British Columbia, Canada
Synaptic Sensing and Modulation by Microglia

Ryuta Koyama, University of Tokyo, Japan
Short Talk: Fever Activates Microglia to Engulf Inhibitory Synapses in Epilepsy

Ukpong B. Eyo, Rutgers University, USA
Short Talk: Bi-Directional Microglial-Neuronal Interactions During Glutamate-Induced Hyperactivity

08:30—23:45
New Treatment Modalities
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
Christer Nordstedt, Eli Lilly and Company, USA
Future Alzheimer's Therapeutics

* Nathalie Isabelle Cartier-Lacave, CEA MIRCen, France
Gene Therapy Strategy for Alzheimer’s Disease: The Cholesterol Connection

Coffee Break

Douglas Golenbock, University of Massachusetts Medical School, USA
The Inflammasome Product IL18 Prevents Amyloid-Induced Fatal Seizures

Fyodor D. Urnov, Sangamo BioSciences, USA
Targeted Genome Regulation for Neurodegenerative Disease Therapy

Claire Le Pichon, NINDS, National Institutes of Health, USA
Short Talk: Loss of Dual Leucine Zipper Kinase Signaling is Protective in the SOD1 Mouse Model of ALS

William J. Meilandt, Genentech, inc., USA
Short Talk: Loss of Dual Leucine Zipper Kinase Signaling is Protective in the PS2APP Mouse Model of Alzheimer’s Disease

11:30—12:30
Lunch

Quandary Peak
12:00—14:30
Poster Session 2

Quandary Peak
14:30—15:30
Workshop 1: Ontogeny and Development

Grays Peak
* Florent Ginhoux, Singapore Immunology Network, Singapore
Modeling Microglial Differentiation and Function in vitro using Induced Pluripotent Stem Cells

Morgane S. Thion, INSERM U1024, France
In utero Development of Microglia: Intrinsic Programs and Impact of Microbiota

Xianhua Piao, Children's Hospital Boston, USA
Microglial Transglutaminase-2 (TG2) Regulates Oligodendrocyte Development and CNS Myelination through GPR56 Signaling

Huixin Xu, Harvard Medical School and Brigham and Women's Hospital, USA
Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid Beta-Protein Oligomers

15:30—16:30
Workshop 2: Models and Techniques I

Grays Peak
* Dimitrios Davalos, Lerner Research Institute, Cleveland Clinic, USA

Steven Marinero, Duke University, USA
3D Brain Tissue-Based Model for Probing Contributions of Microglia and Peripheral Macrophages in Driving Neurodegenerative Disease Mechanisms

Susanna Rosi, University of California, San Francisco, USA
In vivo Metabolic Imaging of Neuroinflammation after TBI

Santiago Sole Domenech, Lund University, Sweden
Intravital Imaging of Acidic Compartments in Mouse Brain Microglia

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Role in Neurodevelopmental and Neuropsychiatric Disorders
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Dorothy Schafer, University of Massachusetts Medical School, USA

Staci Bilbo, Duke Institute for Brain Sciences, USA
Modulation of Microglia by Maternal Immune Activation: Relevance for Autism

Mario R. Capecchi, University of Utah, USA
A Causal Role for Defective Microglia in the OCD-Spectrum Disorder, Trichotillomania

Beth Stevens, Children's Hospital Boston, USA
Microglia Function and Dysfunction During Brain Wiring

17:00—19:00
Role of Glia
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
* Don W. Cleveland, University of California, San Diego, USA
Mechanism and Therapy in ALS and Beyond

Shane A. Liddelow, Stanford University, USA
What Do Reactive Astrocytes Do?

Serge Przedborski, Columbia University, USA
Molecular Mechanism of Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis

Brian V. Lananna, University of Washington in St. Louis, USA
Short Talk: The Astrocyte Circadian Clock Regulates Astrogliosis and Neuronal Injury

19:00
On Own for Dinner


WEDNESDAY, JUNE 15

07:30—08:30
Breakfast

Quandary Peak
08:30—09:15
Special Lecture
Registered attendees can view abstracts starting on 05/12/2016

Marco Prinz, University of Freiburg, Germany
Origin and Function of CNS Macrophages

09:15—11:30
Microglia in Aging and Neurodegenerative Disease
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Thomas Möller, Foundational Neuroscience Center, USA

Marie-Ève Tremblay, Laval University, Canada
Dark Microglia: A New Phenotype Predominantly Associated with Pathological States

Coffee Break

Gary E. Landreth, Case Western Reserve University, USA
Nuclear Receptors License the Phagocytic Clearance of Amyloid by Plaque-Associated Macrophages from the AD Brain

Daniel Wilton, Boston Children’s Hospital, Harvard Medical School, USA
Short Talk: Microglia Mediate Early Loss of Specific Synaptic Connections in Huntington's Disease

Michelle K. Cahill, University of California, San Francisco, USA
Short Talk: Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation

08:30—11:30
RNA and New Mechanisms of Toxicity
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
J. Paul Taylor, HHMI, St. Jude Children's Research Hospital, USA
Disturbed Phase Transitions Underlie Most Forms of ALS and FTD

Eva-Maria Hock, University of Zürich, Switzerland
Short Talk: Understanding the Involvement of Cellular Stress in the Initiation of TDP-43 and FUS Pathology in Slice Culture Models

Maurice S. Swanson, University of Florida, USA
Dynamic Mutations and RNA-Mediated Disease Mechanisms

Coffee Break

* Magdalini Polymenidou, University of Zürich, Switzerland
The Intertwined Roles of RNA Misregulation and Protein Aggregation in ALS and FTD

Josh T. Dubnau, Cold Spring Harbor Laboratory, USA
Short Talk: The Retrotransposon Storm: Retrotransposon Activation Causes Neurodegeneration in a Drosophila TDP-43 Model of Amyotrophic Lateral Sclerosis

11:30—12:30
Panel: Career Development in Biotech and Pharma

Grays Peak
Adam W. Bero, Merck, USA

Irena Kadiu, UCB BioPharma SPRL, Belgium

Morag Stewart, Intellia Therapeutics, USA

Sean Cook, Teva Pharmaceuticals, USA

Peter S. DiStefano, Zebra Biologics, Inc, USA

Timothy S. Zheng, Biogen, USA

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

Quandary Peak
13:00—22:00
Poster Viewing

Quandary Peak
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Profiling Resident Microglia in Health and Disease
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Marco Prinz, University of Freiburg, Germany

Shane A. Liddelow, Stanford University, USA
Identification of Novel Microglia-Specific Markers in Healthy Mouse Brain

Joseph El Khoury, Massachusetts General Hospital, USA
Deep Sequencing Brain Microglia Reveals Unique Molecular Fingerprints

Erik H.W.G.M. Boddeke, University of Groningen, Netherlands
Human and Mouse Microglia Transcriptomes Related to Neurodegeneration and Aging

Brad A. Friedman, Genentech, Inc., USA
Short Talk: The Transcriptional Landscape of Brain Myeloid Cells Reveals Gene Expression Responses Associated with Proliferation, Interferon Signaling and Neurodegeneration

17:00—19:00
Inflammatory Mechanisms
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
Gabor Veres, Bluebird Bio, USA
Clinical Study Update on the Efficacy and Safety of Ex Vivo Gene Therapy with Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy

Richard M. Ransohoff, Biogen, USA
(Re)Introducing Microglia

Jennifer Lee, Johns Hopkins University, USA
Hypothermia and Rewarming Activate a White Matter Macroglial Unfolded Protein Response Independent of Hypoxia-Ischemia in a Piglet Model

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Quandary Peak
19:30—22:00
Poster Session 3

Quandary Peak

THURSDAY, JUNE 16

07:30—08:30
Breakfast

Quandary Peak
08:30—11:45
Microglia Regulation of Pain and Neuronal–Glia Interactions
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Francesca Peri, European Molecular Biology Laboratory, Germany

Richard M. Ransohoff, Biogen, USA
The Fractalkine Story: An Update

Sonia Garel, INSERM, France
Microglia and Prenatal Inflammation in the Development of Cortical Inhibitory Circuits

Coffee Break

Amanda Sierra, Achucarro Basque Center for Neuroscience, Spain
Short Talk: Of Ghost Cells and Ravenous Microglia: Coupling between Apoptosis and Microglial Phagocytosis in Health and Disease

Makoto Tsuda, Kyushu University, Japan
Spinal Microglia Activated by Purinergic Signaling and Neuropathic Pain

Marzia Malcangio, King's College London, UK
Neural-immune Interactions in Chronic Pain Mechanisms

Tuan Trang, University of Calgary, Canada
Short Talk: Pain, Poppies, and Pannexin-1 Channels on Microglia

08:30—11:30
Unfolded Proteins
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
* Richard I. Morimoto, Northwestern University, USA
Proteostasis Disruptions in Aging and Neurodegenerative Disease

David Eisenberg, University of California, Los Angeles, USA
Structural Studies of Toxic and Non-Toxic Amyloid Proteins

Coffee Break

Gordon P. Meares, West Virginia University, USA
Short Talk: Targeting PERK for Selective Immunomodulation in the CNS

Christoph Gericke, University of Zurich, Switzerland
Short Talk: The Influence of Alzheimer’s Disease-Like Cerebral Amyloidosis on Brain Immune Surveillance

David Christopher Wirthensohn, University of Cambridge, UK
Short Talk: Detecting and Characterizing Individual Aggregates in Human CSF

11:45—17:00
On Own for Lunch

14:30—15:30
Workshop 3: Models and Techniques II

Grays Peak
* Beth Stevens, Children's Hospital Boston, USA

Julien A. Muffat, Whitehead Institute for Biomedical Research, USA
Modeling Neuro-Immune Interactions in CNS Disorders using Patient iPS-Derived Microglia-Like Cells

Anne Schaefer, Mount Sinai School of Medicine, USA
Brain Region-Specific Microglia Specification

Edsel M. Abud, University of California, Irvine, USA
Generating Microglia from Human iPSCs to Study Alzheimer’s Disease

Petr Tvrdik, University of Utah, USA
Imaging and Analysis of Intracellular Calcium Dynamics in Cortical Microglia Responding to Injury

15:30—16:30
Brainstorming and Open Discussion

Grays Peak
* Beth Stevens, Children's Hospital Boston, USA

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—18:45
Special Lectures
Registered attendees can view abstracts starting on 05/12/2016

Grays Peak
* Richard M. Ransohoff, Biogen, USA

Adriano M. Aguzzi, University Hospital of Zürich, Switzerland
Immunological Aspects of Prion Diseases

Thomas Möller, Foundational Neuroscience Center, USA
Translating Microglial Biology: Promise and Problems

17:00—18:00
Synaptic Dysfunction in AD, Neurodegenerative Disease, and Developmental Disorders
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
Tara L. Spires-Jones, University of Edinburgh, UK
Dynamic Synaptic Alterations Due to Amyloid Beta and Tau

* Ricardo E. Dolmetsch, Novartis Institutes for BioMedical Research, USA
Synaptic Alterations as a Drug Target

18:00—18:45
Closing Keynote Address
Registered attendees can view abstracts starting on 05/12/2016

Longs Peak
Beth Stevens, Children's Hospital Boston, USA

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Grays Peak
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Longs Peak
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Quandary Peak
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Quandary Peak

FRIDAY, JUNE 17

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

BioLegend, Inc. Ionis Pharmaceuticals, Inc.
Merck & Co., Inc.
 

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13NS096929-01

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Biogen


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

NeuroscientistNews

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676